Causaly
A GTM Engineer at Causaly is responsible for building and evolving a modern, AI-native go-to-market engine to enhance revenue team operations. This role involves owning and optimizing HubSpot for pipelines and workflows, designing automated systems, managing data flows, and troubleshooting GTM friction points. The ideal candidate has 1-4 years of hands-on experience in RevOps or similar roles, is technically curious, and is comfortable experimenting with automation and new tools. Collaboration with Sales, Marketing, and Customer Success teams is essential to translate commercial needs into technical solutions efficiently.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2018
Causaly is an agentic AI platform purpose-built for the life sciences sector, combining advanced AI agents, a high-precision biomedical knowledge graph, and workflow automation to accelerate R&D productivity and decision-making at scale. Its product suite — including Agentic Research, Bio Graph, Pipeline Graph, and Enterprise Data Fabric — supports the full R&D pipeline from target identification and biomarker discovery to regulatory evidence validation. Causaly enables life sciences enterprises to turn complex scientific evidence into decision-ready intelligence with speed, rigor, and repeatability.
Causaly Introduces First Agentic AI Platform Built for Life Sciences Research and Development
Sep 16, 2025
Causaly, an AI platform for drug discovery and biomedical research, raises $60M
Jul 13, 2023
Causaly scores $60M to enhance AI platform for biomedical research
Jul 13, 2023
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Causaly.
Causaly didn’t post a salary, so this is our estimate from similar listings.
Ex-J&J CEO Alex Gorsky joins $60M funding for Causaly's speed-reading drug discovery AI
Jul 13, 2023